Skip to content
10-Q

Quarterly Report

N-Viro International Corporation

0000904896-16-000068

← back to feed
Filed
May 23, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 9, 2016 9.08M sh
Stock Issued Q1 2016 · Apr 30, 2016 100K sh
Capex Q1 2016 · Mar 31, 2016 $0
Capex Q1 2016 · Mar 31, 2015 $13.27K
Operating Cash Flow Q1 2016 · Mar 31, 2016 −$136.37K
Operating Cash Flow Q1 2016 · Mar 31, 2015 −$245.67K
Cash And Equivalents Q1 2016 · Mar 31, 2016 $13.2K
Cash And Equivalents Q1 2016 · Dec 31, 2015 $82.2K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $187.34K
Cash And Equivalents Q1 2016 · Dec 31, 2014 $81.85K
Current Liabilities Q1 2016 · Mar 31, 2016 $2.47M
Current Liabilities Q1 2016 · Dec 31, 2015 $2.32M
Total Liabilities Q1 2016 · Mar 31, 2016 $2.73M
Total Liabilities Q1 2016 · Dec 31, 2015 $2.56M
Current Assets Q1 2016 · Mar 31, 2016 $218.89K
Current Assets Q1 2016 · Dec 31, 2015 $289.93K
Total Assets Q1 2016 · Mar 31, 2016 $702.89K
Total Assets Q1 2016 · Dec 31, 2015 $802.93K
Sga Expense Q1 2016 · Mar 31, 2016 $344.32K
Sga Expense Q1 2016 · Mar 31, 2015 $447.49K
Net Income Q1 2016 · Mar 31, 2016 −$454.52K
Net Income Q1 2016 · Mar 31, 2015 −$486.69K
Operating Income Q1 2016 · Mar 31, 2016 −$367.79K
Operating Income Q1 2016 · Mar 31, 2015 −$451.22K
Gross Profit Q1 2016 · Mar 31, 2016 −$23.47K
Gross Profit Q1 2016 · Mar 31, 2015 −$3.72K
Cost Of Revenue Q1 2016 · Mar 31, 2016 $221.11K
Cost Of Revenue Q1 2016 · Mar 31, 2015 $352.64K
Revenue Q1 2016 · Mar 31, 2016 $197.64K
Revenue Q1 2016 · Mar 31, 2015 $348.92K